Daratumumab (anti-CD38)

Product Name：Daratumumab biosimilar

CAS No.:   945721-28-8                              

Formula:    C₆₄₆₆H₉₉₉₆N₁₇₂₄O₂₀₁₀S₄₂                        

Molecular Weight：  148 kDa                  

Type:    Whole antibody                     

Target：CD38
Antibody Form:  Purified immunoglobulin
Physical Form:   Solution
Storage:  -70±15℃ for long-term storage, 2-8℃ for short-term storage, away from light

Description

Daratumumab biosimilar is an immunoglobulin G1 kappa (IgG1κ) human monoclonal antibody against  CD38 antigen, produced in a mammalian cell line (Chinese Hamster Ovary [CHO]) using recombinant DNA technology. The molecular weight of daratumumab is approximately 148 kDa.

Biological Activity
Daratumumab (anti-CD38) is a recombinant monoclonal antibody to CD38. Daratumumab is an investigational anti-cancer drug which is indicated for the treatment of adult patients with multiple myeloma.

For research use only. Not for use in humans